DOCSLIB.ORG

Supplementary Files

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Files Supplementary Files Table S1. Calibration curves, detection limits and quantification limits for the twelve investigated components (n = 6) of B. chinensis. Analyte Calibration Curve R2 (n = 6) Linear Range (μg/mL) Neomangiferin y = 28.17x + 2.68 0.9999 0.27–55.00 Mangiferin y = 20.76x − 6.51 0.9990 0.35–70.40 Tectoridin y = 94.19x − 37.26 0.9998 3.86–154.50 Iristectorin B y = 82.51x − 10.64 0.9999 1.65–66.00 Iristectorin A y = 49.80x − 43.19 0.9992 1.10–110.00 Iridin y = 60.23x − 11.30 0.9999 1.06–159.00 Tectorigenin y = 95.28x+25.32 0.9999 0.27–108.50 Iristectorigenin A y = 56.82x − 4.84 0.9999 0.16–16.20 Irigenin y = 109.93x + 5.03 0.9998 0.83–41.60 Irisflorentin y = 123.90x − 0.19 0.9993 0.23–11.70 Irilone y = 146.93x − 2.92 0.9992 0.11–4.40 Dictomitin y = 18.20x − 1.47 0.9991 0.59–17.70 y, peak area; x, the concentration of each reference compound (μg/mL). Table S2-1. The data of rhizome of B. chinensis in G1 from different sampling points at 40 °C. a Drying Time (min) T. b Analytes 0 120 240 360 480 600 Moist. c 63.24 ± 0.21 42.31 ± 0.23 27.25 ± 0.06 20.14 ± 0.10 12.04 ± 0.13 8.13 ± 0.06 1 d 2.10 ± 0.07 0.95 ± 0.00 0.50 ± 0.11 1.37 ± 0.00 1.11 ± 0.07 1.17 ± 0.10 2 d 1.84 ± 0.03 1.02 ± 0.01 0.77 ± 0.06 1.20 ± 0.08 1.03 ± 0.05 1.23 ± 0.06 3 d 12.85 ± 0.06 11.12 ± 0.03 10.55 ± 0.03 15.58 ± 0.13 14.36 ± 0.13 14.17 ± 0.04 4 d 1.89 ± 0.12 1.41 ± 0.04 1.19 ± 0.04 2.00 ± 0.08 1.72 ± 0.02 1.83 ±0.02 5 d 6.14 ± 0.03 5.42 ± 0.02 4.72 ± 0.07 6.94 ± 0.10 6.59 ± 0.01 7.74 ± 0.15 40 °C 6 d 7.16 ± 0.03 5.33 ± 0.26 5.25 ± 0.01 7.41 ± 0.17 6.34 ± 0.08 7.21 ± 0.04 7 d 2.09 ± 0.07 2.05 ± 0.12 1.15 ± 0.04 1.20 ± 0.01 1.63 ± 0.13 1.30 ± 0.09 8 d 0.85 ± 0.07 0.94 ± 0.01 0.55 ± 0.02 0.58 ± 0.01 0.65 ± 0.08 0.60 ± 0.01 9 d 3.66 ± 0.03 2.97 ± 0.05 1.99 ± 0.02 2.20 ± 0.05 2.14 ± 0.06 2.39 ± 0.03 10 d 0.91 ± 0.07 0.56 ± 0.00 0.36 ± 0.04 0.46 ± 0.01 0.37 ± 0.04 0.49 ± 0.01 11 d 0.24 ± 0.01 0.19 ± 0.00 0.12 ± 0.02 0.14 ± 0.01 0.10 ± 0.02 0.14 ± 0.02 12 d 0.69 ± 0.05 0.54 ± 0.03 0.80 ± 0.00 0.50 ± 0.04 0.57 ± 0.01 1.05 ± 0.02 a Results are presented as means ± sd (n = 3), Content is the value of dry weight; b Temperature; c Moisture (%); d units: mg/g. Numbering of the compounds is, 1, neomangiferin; 2, mangiferin; 3, tectoridin; 4, iristectorin B; 5, iristectorin A; 6, iridin; 7, tectorigenin; 8, iristectorigenin A; 9, irigenin; 10, irisflorentin; 11, irilone; 12, dichotomitin. S2 Table S2-2. The data of rhizome of B. chinensis in G1 from different sampling points at 50 °C and 60 °C. a Drying Time (min) T. b Analytes 0 60 120 180 240 300 360 420 480 Moist. c 63.24 ± 0.21 47.10 ± 0.39 33.82 ± 0.28 24.66 ± 0.39 14.71 ± 0.34 11.39 ± 0.53 10.25 ± 0.05 8.41 ± 0.33 7.68 ± 0.39 1 d 2.10 ± 0.07 2.07 ± 0.04 2.15 ± 0.11 2.17 ± 0.00 1.97 ± 0.07 1.77 ± 0.10 2.71 ± 0.00 2.45 ± 0.00 2.31 ± 0.02 2 d 1.84 ± 0.03 1.63 ± 0.01 1.77 ± 0.08 2.42 ± 0.02 1.66 ± 0.10 1.44 ± 0.01 1.72 ± 0.04 1.65 ± 0.01 1.56 ± 0.03 3 d 12.85 ± 0.06 15.86 ± 0.05 14.65 ± 0.04 13.84 ± 0.00 14.98 ± 0.06 12.94 ± 0.16 13.40 ± 0.01 13.32 ± 0.01 13.36 ± 0.01 4 d 1.89 ± 0.12 2.05 ± 0.00 2.08 ± 0.17 1.80 ± 0.00 2.21 ± 0.11 2.01 ± 0.10 1.97 ± 0.09 1.89 ± 0.01 1.86 ± 0.02 5 d 6.14 ± 0.03 6.26 ± 0.35 6.15 ± 0.10 6.04 ± 0.00 6.74 ± 0.08 6.30 ± 0.08 6.84 ± 0.01 6.18 ± 0.12 6.35 ± 0.01 50 °C 6 d 7.16 ± 0.03 6.91 ± 0.25 7.28 ± 0.11 7.12 ± 0.00 7.94 ± 0.02 7.55 ± 0.25 7.87 ± 0.03 7.19 ± 0.08 7.58 ± 0.02 7 d 2.09 ± 0.07 1.54 ± 0.01 1.54 ± 0.17 1.92 ± 0.22 1.60 ± 0.03 1.41 ± 0.11 1.39 ± 0.00 1.32 ± 0.01 1.31 ± 0.01 8 d 0.85 ± 0.07 0.83 ± 0.14 0.91 ± 0.09 1.44 ± 0.02 0.87 ± 0.17 0.80 ± 0.34 0.83 ± 0.01 0.76 ± 0.02 0.73 ± 0.00 9 d 3.66 ± 0.03 3.10 ± 0.05 3.51 ± 0.29 6.11 ± 0.10 3.61 ± 0.01 2.54 ± 0.05 3.11 ± 0.02 3.13 ± 0.01 3.05 ± 0.02 10 d 0.91 ± 0.07 0.89 ± 0.04 1.11 ± 0.08 1.92 ± 0.03 1.07 ± 0.08 0.78 ± 0.03 0.90 ± 0.00 0.90 ± 0.01 0.85 ± 0.01 11 d 0.24 ± 0.01 0.23 ± 0.05 0.25 ± 0.01 0.42 ± 0.04 0.26 ± 0.05 0.23 ± 0.06 0.24 ± 0.00 0.21 ± 0.01 0.21 ± 0.01 12 d 0.69 ± 0.05 0.90 ± 0.09 1.16 ± 0.04 1.92 ± 0.01 1.08 ± 0.08 1.00 ± 0.17 1.05 ± 0.00 0.92 ± 0.02 0.90 ± 0.01 Moist. c 63.24 ± 0.21 34.52 ± 0.46 16.00 ± 0.55 8.53 ± 0.32 5.85 ± 0.18 6.20 ± 0.20 4.63 ± 0.25 4.23 ± 0.58 4.08 ± 0.20 1 d 2.10 ± 0.07 1.49 ± 0.05 2.04 ± 0.00 2.10 ± 0.01 1.88 ± 0.05 1.55 ± 0.00 1.65 ± 0.03 1.50 ± 0.08 1.57 ± 0.01 2 d 1.84 ± 0.03 1.62 ± 0.02 1.56 ± 0.02 1.92 ± 0.01 1.65 ± 0.01 1.93 ± 0.11 1.65 ± 0.05 1.53 ± 0.05 2.01 ± 0.01 3 d 12.85 ± 0.06 12.55 ± 0.10 12.58 ± 0.00 13.72 ± 0.10 11.62 ± 0.03 12.09 ± 0.09 11.65 ± 0.03 11.46 ± 0.05 12.92 ± 0.07 4 d 1.89 ± 0.12 1.71 ± 0.03 1.75 ± 0.00 2.01 ± 0.01 1.70 ± 0.00 1.70 ± 0.19 1.69 ± 0.01 1.70 ± 0.04 1.91 ± 0.01 5 d 6.14 ± 0.03 5.67 ± 0.05 5.92 ± 0.10 6.91 ± 0.04 5.78 ± 0.02 5.70 ± 0.02 5.29 ± 0.04 5.54 ± 0.00 6.03 ± 0.03 60 °C 6 d 7.16 ± 0.03 6.29 ± 0.04 7.06 ± 0.10 8.35 ± 0.02 7.14 ± 0.02 7.15 ± 0.19 6.51 ± 0.06 6.50 ± 0.04 7.11 ± 0.04 7 d 2.09 ± 0.07 1.19 ± 0.04 1.33 ± 0.08 1.36 ± 0.08 1.36 ± 0.01 1.23 ± 0.05 1.37 ± 0.01 1.36 ± 0.04 1.53 ± 0.01 8 d 0.85 ± 0.07 0.77 ± 0.02 0.75 ± 0.04 0.86 ± 0.01 0.80 ± 0.00 0.83 ± 0.06 0.88 ± 0.01 0.81 ± 0.06 0.95 ± 0.00 9 d 3.66 ± 0.03 3.06 ± 0.09 3.33 ± 0.04 3.71 ± 0.07 3.56 ± 0.01 3.58 ± 0.07 3.41 ± 0.05 3.28 ± 0.02 3.85 ± 0.02 10 d 0.91 ± 0.07 0.96 ± 0.01 0.97 ± 0.01 1.10 ± 0.05 1.13 ± 0.01 1.12 ± 0.06 1.06 ± 0.07 0.99 ± 0.02 1.12 ± 0.01 11 d 0.24 ± 0.01 0.25 ± 0.00 0.22 ± 0.04 0.27 ± 0.01 0.21 ± 0.05 0.24 ± 0.06 0.22 ± 0.04 0.22 ± 0.00 0.28 ± 0.00 12 d 0.69 ± 0.05 0.78 ± 0.01 0.88 ± 0.05 1.00 ± 0.00 0.95 ± 0.00 0.97 ± 0.10 0.95 ± 0.03 1.01 ± 0.03 0.95 ± 0.00 a Results are presented as means ± sd (n = 3), Content is the value of dry weight; b Temperature; c Moisture (%); d units: mg/g.
Load more

Recommended publications
  • Relation Structure/Activité De Tanins Bioactifs Contre Les Nématodes
    En vue de l'obtention du DOCTORAT DE L'UNIVERSITÉ DE TOULOUSE Délivré par : Institut National Polytechnique de Toulouse (INP Toulouse) Discipline ou spécialité : Pathologie, Toxicologie, Génétique et Nutrition Présentée et soutenue par : Mme JESSICA QUIJADA PINANGO le jeudi 17 décembre 2015 Titre : RELATION STRUCTURE/ACTIVITE DE TANINS BIOACTIFS CONTRE LES NEMATODES GASTROINTESTINAUX (HAEMONCHUS CONTORTUS) PARASITES DES PETITS RUMINANTS Ecole doctorale : Sciences Ecologiques, Vétérinaires, Agronomiques et Bioingénieries (SEVAB) Unité de recherche : Interactions Hôtes - Agents Pathogènes (IHAP) Directeur(s) de Thèse : M. HERVÉ HOSTE Rapporteurs : M. ADIBE LUIZ ABDALLA, UNIVERSIDAD DE SAO PAULO Mme HEIDI ENEMARK, NORWEGIAN VETERINARY INSTITUTE Membre(s) du jury : 1 M. FRANÇOIS SCHELCHER, ECOLE NATIONALE VETERINAIRE DE TOULOUSE, Président 2 M. HERVÉ HOSTE, INRA TOULOUSE, Membre 2 Mme CARINE MARIE-MAGDELAINE, INRA PETIT BOURG, Membre 2 M. SMARO SOTIRAKI, HAO-DEMETER, Membre 2 M. VINCENT NIDERKORN, INRA CLERMONT FERRAND, Membre QUIJADA J. 2015 Cette thèse est dédiée à mes parents, Teresa et Héctor, À mon mari, Rafäel, pour son soutien inconditionnel, son amour illimité, sa patience, sa loyauté, son amitié et surtout sa confidence, À ma grand-mère, Marcolina, car m'ait donné le plus grand et précieux cadeau en ma vie : ma foi en Dieu ma forteresse et mon espoir (Isaïas 41:13). À mes adorés sœurs, belle- sœurs et frère : Yurlin, Indira, Iskay, Olga, Zoraida et Jesus. Merci pour l’amour infini que m’ont toujours été donné, celui qu’a été prolongé par l'amour de mes merveilleux neveux. 1 QUIJADA J. 2015 REMERCIEMENTS Je remercie tout d’abord mon Dieu pour me donner le cadeau de la vie, et la forteresse pour vivre chaque jour.
    [Show full text]
  • IN SILICO ANALYSIS of FUNCTIONAL Snps of ALOX12 GENE and IDENTIFICATION of PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS
    Tulasidharan Suja Saranya et al. Int. Res. J. Pharm. 2014, 5 (6) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 – 8407 Research Article IN SILICO ANALYSIS OF FUNCTIONAL SNPs OF ALOX12 GENE AND IDENTIFICATION OF PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS LIPOXYGENASE INHIBITORS Tulasidharan Suja Saranya, K.S. Silvipriya, Manakadan Asha Asokan* Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Viswa Vidyapeetham University, AIMS Health Sciences Campus, Kochi, Kerala, India *Corresponding Author Email: [email protected] Article Received on: 20/04/14 Revised on: 08/05/14 Approved for publication: 22/06/14 DOI: 10.7897/2230-8407.0506103 ABSTRACT Cancer is a disease affecting any part of the body and in comparison with normal cells there is an elevated level of lipoxygenase enzyme in different cancer cells. Thus generation of lipoxygenase enzyme inhibitors have suggested being valuable. Individual variation was identified by the functional effects of Single Nucleotide Polymorphisms (SNPs). 696 SNPs were identified from the ALOX12 gene, out of which 73 were in the coding non-synonymous region, from which 8 were found to be damaging. In silico analysis was performed to determine naturally occurring flavonoids such as isoflavones having the basic 3- phenylchromen-4-one skeleton for the pharmacological activity, like Genistein, Diadzein, Irilone, Orobol and Pseudobaptigenin. O-methylated isoflavones such as Biochanin, Calycosin, Formononetin, Glycitein, Irigenin, 5-O-Methylgenistein, Pratensein, Prunetin, ψ-Tectorigenin, Retusin and Tectorigenine were also used for the study. Other natural products like Aesculetin, a coumarin derivative; flavones such as ajoene and baicalein were also used for the comparative study of these natural compounds along with acteoside and nordihydroguaiaretic acid (antioxidants) and active inhibitors like Diethylcarbamazine, Zileuton and Azelastine as standard for the computational analysis.
    [Show full text]
  • Phylogenetic Insights on the Isoflavone Profile Variations In
    Food Research International 76 (2015) 51–57 Contents lists available at ScienceDirect Food Research International journal homepage: www.elsevier.com/locate/foodres Phylogenetic insights on the isoflavone profile variations in Fabaceae spp.: Assessment through PCA and LDA Tatiana Visnevschi-Necrasov a,b, João C.M. Barreira b,c,⁎,SaraC.Cunhab, Graça Pereira d, Eugénia Nunes a, M. Beatriz P.P. Oliveira b a CIBIO-ICETA, Faculdade de Ciências, Universidade do Porto, R. Padre Armando Quintas 4485-661 Vairão, Portugal b REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, No. 228, 4050-313, Porto,Portugal c CIMO-ESA, Instituto Politécnico de Bragança, Campus de Santa Apolónia, Apartado 1172, 5301-855 Bragança, Portugal d INRB/IP — INIA — Instituto Nacional de Recursos Biológicos, Caia E São Pedro Estrada Gil Vaz, 7350-228 Elvas, Portugal article info abstract Article history: Legumes (Fabaceae) are important crops, known as sources of food, feed for livestock and raw materials for in- Received 30 September 2014 dustry. Their ability to capture atmospheric nitrogen during symbiotic processes with soil bacteria reduces the Received in revised form 15 November 2014 need for expensive chemical fertilizers, improving soil and water quality. Several Fabaceae species are acknowl- Accepted 20 November 2014 edged for the high levels of secondary metabolites. Isoflavones are among the most well-known examples of Available online 28 November 2014 these compounds, being recognized for their several types of biological activity. Herein, isoflavone profiles were characterized in nine species of four Fabaceae genera (Biserrula, Lotus, Ornithopus and Scorpiurus). Plants Chemical compounds studied in this article: fl Daidzin (PubChem CID: 107971) were harvested in the late ower physiological stage to prevent biased results due to naturally occurring varia- Genistin (PubChem CID: 5281377) tions along the vegetative cycle.
    [Show full text]
  • PDF-Document
    Supplementary Materials 1 Metabolomics profiling analysis of red clover Table S1. Compound identification of red clover in positive and negative ion modes. MS1 No RT Ion Ion Measur Predicte Ste Le Flow Err MS2 MS3 Identification . min Form Formula ed d m af er ppm m/z m/z [M − 195.050 1 1.43 C6H11O7 195.0499 2.82 Gluconic acid ++ ++ +++ H]- 5 179.03506(C9H7O4); Benzoylcitronensa [M − 295.045 295.0448 ++ 2 4.46 C13H11O8 0.67 133.01451(C4H5O5); [295-179]135.04524(C8H7O2); ure ++ +++ H]- 0 4 + 115.00400(C4H3O4); [M + 355.102 ++ 3 5.42 C16H19O9 355.1024 1.21 chlorogenic acid + +++ H]+ 8 + [433-271]253.04956(C15H9O4); 243.06529(C14H11O4); [M + 433.111 Genistein- ++ 4 6.60 C21H21O10 433.1129 −3.54 271.06067(C15H11O5); 215.07042(C13H11O3); +++ +++ H]+ 4 glucoside + 153.01839(C7H5O4); 149.02335(C8H5O3); [M + 417.117 5 6.71 C21H21O9 417.1180 −2.34 239.07021(C15H11O3) daidzin + ++ +++ H]+ 0 [M + 447.127 calycosin-7-O-β-D- ++ 6 7.20 C22H23O10 447.1286 −1.91 269.08072(C16H13O4) +++ +++ H]+ 7 glucoside + 1 [533-285]270.05258(C15H10O5); Calycosin-7-O-β- [M + 533.127 253.04982(C15H9O4); ++ 7 8.03 C25H25O13 533.1290 −3.54 285.07642(C16H13O5); D-glucoside 4′′-O- +++ +++ H]+ 1 225.05478(C14H9O3); + malonate 137.02333(C7H5O3); [M + 433.112 ++ 8 8.95 C21H21O10 433.1129 −2.11 255.06516(C15H11O4) genistin ++ +++ H]+ 0 + [519-271]253.04958(C15H9O4,); Genistein- 243.06526(C14H11O4); [M + 519.111 433.11377(C21H21O10); glucoside ++ 9 9.31 C24H23O13 519.1133 −3.25 215.07045(C13H11O3); - +++ H]+ 6 271.06073(C15H11O5); malonate + 153.01833(C7H5O4); 149.02333(C8H5O3);
    [Show full text]
  • Chemical Properties Biological Description Solubility Information
    Data Sheet (Cat.No.TN2100) Pratensein Chemical Properties CAS No.: 2284-31-3 Formula： C16H12O6 Molecular Weight： 300.3 Appearance： N/A Storage： 0-4℃ for short term (days to weeks), or -20℃ for long term (months). Biological Description Description Pratensein as a novel transcriptional up-regulator of scavenger receptor class B type I in HepG2 cells. Targets(IC50) AChR: None NF-κB: None Beta Amyloid: None In vitro Protective effect of five isoflavones (formononetin, daidzein, Pratensein, calycosin and irilone) from Trifolium pratense on lipopolysaccharide-induced dopaminergic neurodegeneration was studied for the first time. The results showed that all five isoflavones attenuated LPS-induced decrease in dopamine uptake and the number of dopaminergic neurons in a dose-dependent manner in rat mesencephalic neuron-glia cultures. Moreover, they also significantly inhibited LPS-induced activation of microglia and production of tumor necrosis factor-alpha, nitric oxide and superoxide in mesencephalic neuron-glia cultures and microglia-enriched cultures. In addition, the rank order of protective potency of five isoflavones was: Pratensein>daidzein>calycosin>formononetin>irilone. Solubility Information Solubility < 1 mg/ml refers to the product slightly soluble or insoluble Preparing Stock Solutions 1mg 5mg 10mg 1 mM 3.330 mL 16.650 mL 33.300 mL 5 mM 0.666 mL 3.330 mL 6.660 mL 10 mM 0.333 mL 1.665 mL 3.330 mL 50 mM 0.067 mL 0.333 mL 0.666 mL Please select the appropriate solvent to prepare the stock solution, according to the solubility of the product in different solvents. The storage conditions and period of the stock solution: - 80 ℃ for 6 months; - 20 ℃ for 1 month.
    [Show full text]
  • ( 12 ) United States Patent
    US010722444B2 (12 ) United States Patent ( 10 ) Patent No.: US 10,722,444 B2 Gousse et al. (45 ) Date of Patent : Jul. 28 , 2020 (54 ) STABLE HYDROGEL COMPOSITIONS 4,605,691 A 8/1986 Balazs et al . 4,636,524 A 1/1987 Balazs et al . INCLUDING ADDITIVES 4,642,117 A 2/1987 Nguyen et al. 4,657,553 A 4/1987 Taylor (71 ) Applicant: Allergan Industrie , SAS , Pringy (FR ) 4,713,448 A 12/1987 Balazs et al . 4,716,154 A 12/1987 Malson et al. ( 72 ) 4,772,419 A 9/1988 Malson et al. Inventors: Cécile Gousse , Dingy St. Clair ( FR ) ; 4,803,075 A 2/1989 Wallace et al . Sébastien Pierre, Annecy ( FR ) ; Pierre 4,886,787 A 12/1989 De Belder et al . F. Lebreton , Annecy ( FR ) 4,896,787 A 1/1990 Delamour et al. 5,009,013 A 4/1991 Wiklund ( 73 ) Assignee : Allergan Industrie , SAS , Pringy (FR ) 5,087,446 A 2/1992 Suzuki et al. 5,091,171 A 2/1992 Yu et al. 5,143,724 A 9/1992 Leshchiner ( * ) Notice : Subject to any disclaimer , the term of this 5,246,698 A 9/1993 Leshchiner et al . patent is extended or adjusted under 35 5,314,874 A 5/1994 Miyata et al . U.S.C. 154 (b ) by 0 days. 5,328,955 A 7/1994 Rhee et al . 5,356,883 A 10/1994 Kuo et al . (21 ) Appl . No.: 15 /514,329 5,399,351 A 3/1995 Leshchiner et al . 5,428,024 A 6/1995 Chu et al .
    [Show full text]
  • Pharmacology and Phytochemistry of Isoflavonoids from Iris Species
    Journal of Pharmacology & Clinical Research ISSN: 2473-5574 Review Article J of Pharmacol & Clin Res - Volume 3 Issue 2 July 2017 Copyright © All rights are reserved by Afroze Alam DOI: 10.19080/JPCR.2017.03.555609 Pharmacology and Phytochemistry of Isoflavonoids from Iris Species Disha Choudhary and Afroze Alam*1,2,3 1Institute of Pharmacy, Shri Jagdish Prasad Jhabarmal Tibrewala University, India 2Narayan Institute of Pharmacy, India 3School of Pharmacy, Shoolini University, India Submission: June 16, 2016; Published: July 13, 2017 *Corresponding author: Afroze Alam, Narayan Institute of Pharmacy, Jamuhar, Sasaram (Rohtas)-821305(Bihar)-India, Tel: ; Fax: ; Email: ; Abstract Iris is the largest and most complicated genus of family Iridaceae. Irises are mainly used as the ornamental plants, due to their colorful iris species species of iris have resulted in the isolation of flowers, or in the perfume industry, due to their violet like fragrance, but lot of were also used in many part of the worldsiris as medicinal plants for healing of a wide spectrum of diseases. The phytochemical investigations of various variety of secondary metabolites. Approximately more than two hundred compounds have been reported from the genus which includes flavonoids, isoflavonoids and their glycosides, benzoquinones triterpenoids and stilbenes glycosides. This genus is rich in isoflavonoidsIris which have a wide range of biological activity including anti-inflammatory, antioxidant and cancer chemo preventive properties. Nowadays phytochemical and pharmacological investigations bring new knowledge about chemical compounds in roots, leaves and flowers of the species, about their chemical content and possible pharmacological and medicinal usage. This review brings suchtogether as cancer, results cardiovascular of the iris research disorder, in last and few osteoporosisor decades, putting against together the bacterial the information and viral about infections.
    [Show full text]
  • Senate Commission on Food Safety
    DFG - Senate Commission on Food Safety Prof. Dr. G. Eisenbrand - President SKLM Isoflavones as phytoestrogens in food supplements and dietary foods for special medical purposes English Version: May 23rd 2007 Released in German: November 10th 2006 (altered version: February 20th 2009) University of Kaiserslautern Food Chemistry and Environmental Toxicology Erwin-Schroedinger-Straße 52 D-67663 Kaiserslautern Germany Isoflavones with estrogen-like activities are used as ingredients in food supplements and dietary foods for special medical purposes, advertised primarily to women in menopause. The DFG Senate Commission on Food Safety (SKLM) has evaluated the safety of phytoestrogenic isoflavones in food supplements and in supplementary balanced diets together with external experts. Data on their content in foods and food supplements, dietary intake, bioavailability, metabolism, biological effects and toxicity have been considered as well. The German opinion was adopted on 10th November 2006, the English version was accepted on 23rd May 2007. Isoflavones as phytoestrogens in food supplements and dietary foods for special medical purposes Preamble The Senate Commission on Food Safety (SKLM) has addressed issues concerning potential adverse effects caused by polyphenols/flavonoids used in an isolated or enriched form in the past and has adopted a corresponding opinion (SKLM, 2003). In addition, criteria for the evaluation of functional foods (SKLM, 2005) as well as an opinion on the evaluation of food supplements with constituents other than vitamins and minerals (SKLM, 2006) have been published. Food supplements and dietary foods based on soy or red clover are frequently rich in isoflavones that may have an estrogenic effect. This has prompted the SKLM to reevaluate the safety of this group of substances.
    [Show full text]
  • Current Organic Chemistry, 2017, 21, 218-235 REVIEW ARTICLE
    Send Orders for Reprints to [email protected] 218 Current Organic Chemistry, 2017, 21, 218-235 REVIEW ARTICLE ISSN: 1385-2728 eISSN: 1875-5348 Impact Factor: Isoflavones, their Glycosides and Glycoconjugates. Synthesis and Biological Activity 1.949 BENTHAM SCIENCE Wiesaw Szeja1*, Grzegorz Grynkiewicz2 and Aleksandra Rusin3 1Silesian Technical University, Department of Chemistry, Krzywoustego 4, 44-100 Gliwice, Poland; 2Pharmaceutical Research Insti- tute, Rydygiera 8, 01-793 Warszawa, Poland; 3Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze AK 15, 44-100 Gliwice, Poland Abstract: Glycosylation of small biologically active molecules, either of natural or synthetic origin, has a pro- found impact on their solubility, stability, and bioactivity, making glycoconjugates attractive compounds as therapeutic agents or nutraceuticals. A large proportion of secondary metabolites, including flavonoids, occur in plants as glycosides, which adds to the molecular diversity that is much valued in medicinal chemistry studies. The subsequent growing market demand for glycosidic natural products has fueled the development of various chemical and biotechnological methods of glycosides preparation. The review gives an extensive overview of the A R T I C L E H I S T O R Y processes of the synthesis of isoflavones and discusses recently developed major routes towards isoflavone-sugar Received: May 05, 2016 formation processes. Special attention is given to the derivatives of genistein, the main isoflavone recognized as a Revised: July 20, 2016 useful lead in several therapeutic categories, with particular focus on anticancer drug design. The utility of Accepted: September 22, 2016 chemical glycosylations as well as glycoconjugates preparation is discussed in some theoretical as well as practi- DOI: cal aspects.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2017/0020950 A1 Lambers Et Al
    US 20170020950A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2017/0020950 A1 Lambers et al. (43) Pub. Date: Jan. 26, 2017 (54) METHODS FOR MODULATING KINASES (52) U.S. Cl. CPC ............. A61K 38/018 (2013.01); A61K 35/74 (71) Applicant: Mead Johnson Nutrition Company, (2013.01); A61K 35/741 (2013.01); A61 K Glenview, IL (US) 3 1/716 (2013.01); A23L I/296 (2013.01); A2.3L I/3056 (2013.01); A23 V 2002/00 (72) Inventors: Teartse Tim Lambers, Nijmegen (NL); (2013.01) Eric A.F. van Tol, Arnhem (NL); Sarmauli Manurung, Nijmegen (NL) (57) ABSTRACT (21) Appl. No.: 14/806,877 A method for modulating a kinase by administering to a (22) Filed: Jul. 23, 2015 Subject a nutritional composition comprising extensively hydrolyzed casein, extensively hydrolyzed casein fractions, Publication Classification or combinations thereof. A modulated kinase may be a (51) Int. Cl. kinase that regulates inflammatory signaling, immune tol A6 IK 38/0 (2006.01) erance, metabolic signaling, cell cycle and growth factor A6 IK 35/74 (2006.01) signaling. The nutritional composition may dose-depend A6 IK3I/76 (2006.01) ently inhibit a range of serine, threonine and tyrosine A6 IK 35/74 (2006.01) kinases. US 2017/0020950 A1 Jan. 26, 2017 METHODS FOR MODULATING KNASES 0010. The nutritional composition in the disclosed method may be an infant formula, and may, in Some embodi TECHNICAL FIELD ments, further comprise fat, carbohydrate, probiotic, prebi 0001. This disclosure relates to methods of modulating otic, or combinations thereof. The prebiotic may include specific kinase activity by administering extensively hydro polydextrose and/or galacto-oligosaccharide.
    [Show full text]
  • Ruth N. Muchiri, and Richard B. Van Breemen Linus Pauling Institute
    SINGLE LABORATORY VALIDATION OF UHPLC-MS/MS ASSAY OF RED CLOVER Ruth N. Muchiri,1 and Richard B. van Breemen1 1Linus Pauling Institute, Oregon State University, 2900 SW Campus Way, Corvallis, Oregon USA. OBJECTIVES RESULTS • Develop and validate UHPLC-MS/MS assay for red clover • Base line separation of all 6 red clover isoflavones was obtained in 5 min during UHPLC • All analytes were stable in the autosampler (10 °C) for 24 h (covers the time for injection and isoflavones in dietary supplements and human serum • No interfering peaks were observed at the same retention times as the isoflavones (Figure 3) UHPLC-MS/MS of all analytes processed at any specific validation study (Table 3). • Apply the validated method to standardize red clover extract and • The standard curves were linear from the LLOQ to the ULOQ concentrations for all compounds • Freeze-thaw cycle of analytes in human serum matrix post extraction were stable after 2 cycles. 2 dietary supplement products, and analyze serum samples from with a R >0.999. The standards were spiked in human serum matrix (Figure 4 & Table 1). • The QCs were within the acceptance criteria: Below 15% for L, M, and H; and below 20% at LLOQ. clinical trials • The mean recovery (based on low, medium and high QC (quality control) standards ranged • The intraday and interday coefficients of variation obtained from all the isoflavones were <13% between 80 and 108% in serum matrix (Table 2). except for daidzein at low concentration (Table 4). Table 3. Stability studies of red clover isoflavones (%). BACKGROUND A Figure 4.
    [Show full text]
  • (L) DC and Iris Tectorum Maxim Based on Plant Metabolomics, D
    Zhou et al. Chin Med (2021) 16:85 https://doi.org/10.1186/s13020-021-00494-3 Chinese Medicine RESEARCH Open Access A novel multidimensional strategy to evaluate Belamcanda chinensis (L) DC and Iris tectorum Maxim based on plant metabolomics, digital reference standard analyzer and biological activities evaluation Hongxu Zhou1,2†, Yi Zhang2†, Hui Liang1, Huijie Song1, Jiaming Zhao1, Li Liu1, Jun Zeng2, Lei Sun3, Shuangcheng Ma3* and Dali Meng1* Abstract Background: Belamcanda chinensis (L.) DC. (BC) belongs to the family of Iridaceae and is widely cultivated and used in many Chinese patent medicine and Chinese medicinal formulae. However, due to the high similarities in appear- ance such as color and shape to Iris tectorum Maxim (ITM), another plant from the same family, BC is often confused or even misused with ITM. Methods: Therefore, in order to distinguish the chemical constituents, qualities and biological activities of BC and ITM, multiple technologies including plant metabolomics, digital reference standard (DRS) analyzer and biological activities assay were employed to provide a sufcient basis for their practical applications. Results: In plant metabolomics, the PCA and OPLS-DA score plot indicated the obvious diferences in chemical profling between BC and ITM and 6 compounds were successfully identifed to contribute to the diferences. In DRS study, the fngerprints of 10 and 8 compounds in BC and ITM were developed based on DRS analyzer, respectively, involving relative retention time (RRT) method and linear calibration using two reference substances (LCTRS) tech- nique. The DRS analyzer also accurately identifed 10 and 8 compounds from BC and ITM, respectively, by using only two reference standards.
    [Show full text]